F · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $187.27B | $184.99B | $176.19B | $158.06B | $136.34B | $127.14B | $155.90B | $160.34B |
| Cost of Revenue | $174.47B | $158.43B | $150.55B | $134.40B | $114.65B | $112.75B | $134.69B | $136.27B |
| Research & Development | $9.40B | $8.00B | $8.20B | $7.80B | $7.60B | $7.10B | $7.40B | $8.20B |
| Selling, General & Administrative | $10.85B | $10.29B | $10.70B | $10.89B | $11.91B | $10.19B | $11.16B | $11.40B |
| Operating Expenses | $196.44B | $179.77B | $170.73B | $151.78B | $131.82B | $131.55B | $155.33B | $157.13B |
| Operating Income | -$9.17B | $5.22B | $5.46B | $6.28B | $4.52B | -$4.41B | $574.00M | $3.20B |
| Interest Expense | — | — | $7.61B | $4.59B | $4.59B | $5.05B | $5.41B | $5.16B |
| Other Income / (Expense) | $1.75B | $2.45B | -$603.00M | -$5.15B | $14.73B | $4.90B | -$226.00M | $2.25B |
| Income Before Taxes | -$11.83B | $7.23B | $3.97B | -$3.02B | $17.78B | -$1.12B | -$640.00M | $4.34B |
| Provision for Income Taxes | -$3.67B | $1.34B | -$362.00M | -$864.00M | -$130.00M | $160.00M | -$724.00M | $650.00M |
| Net Income | -$8.16B | $5.88B | $4.35B | -$1.98B | $17.94B | -$1.28B | $84.00M | $3.69B |
| Basic EPS | -$2.06 | $1.48 | $1.09 | -$0.49 | $4.49 | -$0.32 | $0.01 | $0.93 |
| Diluted EPS | -$2.06 | $1.46 | $1.08 | -$0.49 | $4.45 | -$0.32 | $0.01 | $0.92 |
| Basic Shares Outstanding | 3.98B | 3.98B | 4.00B | 4.01B | 3.99B | 3.97B | 3.97B | 3.97B |
| Diluted Shares Outstanding | 3.98B | 4.02B | 4.04B | 4.01B | 4.03B | 3.97B | 4.00B | 4.00B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $1.86 | $1.79 | $1.93 | 8 | ↑8 ↓0 |
| Dec 2027 | $1.94 | $1.85 | $2.07 | 8 | ↑6 ↓1 |
| Dec 2028 | $2.11 | $2.00 | $2.28 | 4 | ↑2 ↓1 |
| Dec 2029 | $2.80 | $2.80 | $2.80 | 1 | ↑0 ↓1 |